ID: ALA3746445

Max Phase: Preclinical

Molecular Formula: C25H30N2O5

Molecular Weight: 438.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(OCc1ccc(C23CC4CC(CC(C4)C2)C3)cc1)c1cc(N(O)C2CCCO2)on1

Standard InChI:  InChI=1S/C25H30N2O5/c28-24(21-11-23(32-26-21)27(29)22-2-1-7-30-22)31-15-16-3-5-20(6-4-16)25-12-17-8-18(13-25)10-19(9-17)14-25/h3-6,11,17-19,22,29H,1-2,7-10,12-15H2

Standard InChI Key:  ZPBVBAGLRHZELG-UHFFFAOYSA-N

Associated Targets(non-human)

Seed lipoxygenase-1 463 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4256 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 438.52Molecular Weight (Monoisotopic): 438.2155AlogP: 4.83#Rotatable Bonds: 6
Polar Surface Area: 85.03Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.31CX Basic pKa: CX LogP: 4.88CX LogD: 5.08
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.51Np Likeness Score: -0.51

References

1. Averina EB, Vasilenko DA, Gracheva YA, Grishin YK, Radchenko EV, Burmistrov VV, Butov GM, Neganova ME, Serkova TP, Redkozubova OM, Shevtsova EF, Milaeva ER, Kuznetsova TS, Zefirov NS..  (2016)  Synthesis and biological evaluation of novel 5-hydroxylaminoisoxazole derivatives as lipoxygenase inhibitors and metabolism enhancing agents.,  24  (4): [PMID:26753816] [10.1016/j.bmc.2015.12.040]

Source